Please login to the form below

Not currently logged in


This page shows the latest Menarini news and features for those working in and with pharma, biotech and healthcare.

New cancer meds and drug extensions top CHMP recommendations

New cancer meds and drug extensions top CHMP recommendations

This includes Adenuric, blockbuster oncology treatment Avastin (bevacizumab) from Roche; AbbVie's auto-inflammatory drug Humira (adalimumab), Menarini's gout drug Adenuric, (febuxostat), the rare disease drug for kidney disease Soliris

Latest news

More from news
Approximately 4 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • Pharma deals in April 2015 Pharma deals in April 2015

    Dr Reddy's, Menarini and Cipher Pharmaceuticals have acquired or licensed rights to products in South Asia, Asia Pacific (ex-Japan) and North America and Mexico, respectively.  . ... Menarini AP will be responsible for the clinical development,

  • Medius Deal Watch table for April 2015 Medius Deal Watch table for April 2015

    120. 4SC AG/Menarini. Licensing and development agreement. Resminostat (oral HDAC) for hepatocellular carcinoma.

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    130‡. Vivus / Berlin-Chemie  (Menarini). Licence, commercialisation, supply. Spedra (avanafil) for erectile dysfunction (approved).

  • Pharma investment in Indonesia Pharma investment in Indonesia

    Two years prior to its acquisition by the Italian Menarini group in Dec 2012, the Invida Group acquired 70 per cent stake of Indonesian pharmaceutical manufacturer MUGI.

  • Pharma deals during October 2012 Pharma deals during October 2012

    indications. Whilst Oxford BioTherapeutics will be responsible for the discovery activities, Menarini will lead on the manufacture and clinical development of each programme. ... Asia and Latin America. Whilst no financial terms have been disclosed, a

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Frontera Group Frontera Group

    Medskin Solutions . Menarini Farmaceutica Internazionale . Merck. Merz Pharmaceuticals. Mitsubishi Pharma Europe.

  • Life wins at the Rx Club Show

    Menarini. Life also picked up 6 awards of excellence in the print category for Life self-promotion and for clients Galderma and Abbott. .


    Alimera. Bayer. BD. Celgene. Dr Falk. GE. Jazz. Menarini. MSD. Myzone.

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...